LA JOLLA PHARMACEUTICAL CO
10% Owner | 2020-07-29 17:24:15 | 0
4,822,360 | 4,822,360 | Form 4 |
TTP Merger Sub Inc.
10% Owner | 2020-08-11 14:56:14 | 3,737,360
0 | 3,737,360 | Form 3 |
CMEA VENTURES VI LP
CMEA Ventures VI GmbH & Co. KG
CMEA Ventures VI Management L.P.
Handelsman Karl D.
Collier David J
Watson James F
Sohail Faysal A.
BARUCH THOMAS R
10% Owner | 2014-02-14 13:30:59 | 1,708,962
0 | 1,708,962 | Form 13G |
CMEA VENTURES VI LP
CMEA Ventures VI GmbH & Co. KG
CMEA Ventures VI Management L.P.
BARUCH THOMAS R
Collier David J
Sohail Faysal A.
Watson James F
10% Owner | 2014-02-14 13:30:59 | 1,708,962
0 | 1,708,962 | Form 13G |
MEDIPHASE VENTURE PARTNERS II LP
Mediphase Venture Partners (DP&UP) Limited Partnership
Mediphase Venture Partners II (Annex Fund) Limited Partnership
Mediphase Venture Partners II (Select Fund) Limited Partnership
Mediphase II LLC
Mediphase (DP&UP) LLC
Mediphase II (Annex Fund) LLC
Mediphase II (Select Fund) LLC
Miller Lawrence G.
Howard Paul Anthony
10% Owner | 2015-02-13 17:11:01 | 1,501,361
0 | 1,501,361 | Form 13G |
ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
Director
10% Owner | 2020-07-30 20:04:47 | 1,419,507
0 | 1,419,507 | Form 4 |
La Jolla Pharmaceutical Holdings LLC
10% Owner | 2020-08-07 20:35:37 | 1,085,000
0 | 1,085,000 | Form 3 |
FMR LLC
See Remark 1 | 2018-02-13 09:47:42 | 989,234
0 | 989,234 | Form 13G |
Flagship Ventures Fund 2004 L P
Flagship Ventures Fund 2007 L.P.
Flagship Ventures 2007 General Partner LLC
Flagship Ventures General Partner LLC
AFEYAN NOUBAR
KANIA EDWIN M JR
10% Owner | 2014-02-20 16:21:53 | 891,086
0 | 891,086 | Form 13D |
Skyline Venture Partners Qualified Purchaser Fund IV L P
Skyline Venture Management IV LLC
KANEKO YASUNORI
HOFFMAN STEPHEN J
10% Owner | 2014-03-14 14:43:00 | 0
308,986 | 308,986 | Form 4 |
Myers Andrew
10% Owner | 2013-03-19 21:35:11 | 275,862
0 | 275,862 | Form 3 |
Tsai Larry
Chief Medical Officer | 2019-01-18 18:05:32 | 213,561
0 | 213,561 | Form 4 |
Lubner David Charles
SVP and CFO | 2015-08-17 17:03:51 | 193,069
0 | 193,069 | Form 4 |
Dumas Jacques
Chief ScientificOfficer | 2019-01-18 18:00:57 | 180,000
0 | 180,000 | Form 4 |
THOMPSON JOHN CRAIG
Chief Operating Officer | 2015-09-10 21:14:08 | 157,844
0 | 157,844 | Form 4 |
Ronn Magnus
10% Owner | 2013-03-19 21:22:43 | 98,177
0 | 98,177 | Form 3 |
Webster Leland
10% Owner | 2013-03-19 21:31:02 | 65,452
0 | 65,452 | Form 3 |
Horn Patrick Taylor
Chief Medical Officer | 2017-06-14 16:07:59 | 57,689
0 | 57,689 | Form 4 |
Trias Joaquim
10% Owner | 2013-03-27 20:17:50 | 52,569
0 | 52,569 | Form 4 |
Unninayar Kamalam
Chief Financial Officer | 2018-01-19 19:48:43 | 40,000
0 | 40,000 | Form 4 |
Cole Douglas G.
Director | 2013-05-20 19:00:36 | 20,000
0 | 20,000 | Form 4/A |
Sutcliffe Joyce A.
Senior Vice President, Biology | 2014-03-21 09:26:56 | 17,242
0 | 17,242 | Form 4 |
BOHLIN GAREN G
Director | 2019-06-11 19:17:10 | 16,500
0 | 16,500 | Form 4 |
Chodakewitz Jeffrey
Director | 2019-06-11 19:17:46 | 16,500
0 | 16,500 | Form 4 |
HENWOOD GERALDINE
Director | 2019-06-11 19:20:50 | 16,500
0 | 16,500 | Form 4 |
Wysenski Nancy
Director | 2019-06-11 19:22:07 | 16,500
0 | 16,500 | Form 4 |
Gullans Steven R. Ph.D.
Director | 2014-06-16 08:52:17 | 10,000
0 | 10,000 | Form 4 |
Xiao Xiao-Yi
10% Owner | 2013-03-27 20:05:54 | 9,033
0 | 9,033 | Form 4 |
Stahl Maria D
See Remarks | 2020-07-29 16:10:14 | 0
0 | 0 | Form 4 |
GAGE L PATRICK
Director | 2020-07-29 16:14:23 | 0
0 | 0 | Form 4 |
Macdonald Guy
Director | 2020-07-29 16:18:29 | 0
0 | 0 | Form 4 |
Edwards Larry G.
See Remarks | 2020-07-29 16:18:34 | 0
0 | 0 | Form 4 |
Watt Christopher
Senior Vice President, Finance | 2020-07-29 16:27:55 | 0
0 | 0 | Form 4 |
Maher Illya Keith
Director | 2020-01-31 18:01:15 | 0
0 | 0 | Form 3 |
Freund John Gordon
Director | 2019-12-12 21:35:07 | 0
0 | 0 | Form 4 |
EXCEL MEDICAL FUND LP
Blume Frederick R.
Enriquez Juan
Petrillo Enrico
Excel Medical Ventures LLC
10% Owner | 2015-02-05 16:28:34 | 0
0 | 0 | Form 13G |
Giroir L. Patrick Jr.
Incorrect prior filing | 2015-06-12 13:19:52 | 0
0 | 0 | Form 4/A |